PMID: 6161627Jan 1, 1981Paper

The pharmacology of atracurium: a new competitive neuromuscular blocking agent

British Journal of Anaesthesia
R Hughes, D J Chapple

Abstract

Atracurium besylate, 2,2'-(3,11-dioxo-4,10-dioxatridecylene)-bis-[6,7-dimethoxy-1-(3,4-dimethoxy-benzyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium] dibenzenesulphonate, is one of a new series of competitive neuromuscular blocking agents. An i.v. dose of 0.25 mg kg-1 produced complete paralysis in anaesthetized cats, dogs and rhesus monkeys; paralysis was of medium duration and was readily antagonized by neostigmine. Vagal blockade occurred only after doses 8--16 times greater than the full neuromuscular paralysing dose and effects on sympathetic mechanisms were minimal. Hypotension and bradycardia were evident after supramaximal doses of 4 mg kg-1 i.v. and these effects, together with circulatory depression, were probably attributable to histamine release. In vitro studies have shown that the non-enzymic decomposition of atracurium by "Hofmann Elimination" was enhanced by increasing pH. In vivo neuromuscular paralysis was significantly reduced when the arterial pH was increased. There were indications that neither the liver nor the kidney plays a major role in the metabolism and elimination of unchanged drug. These results are of sufficient interest to merit the evaluation of atracurium in anaesthetized man.

Citations

Sep 1, 1982·Klinische Wochenschrift·J MossJ J Savarese
Mar 1, 1986·Canadian Anaesthetists' Society Journal·M D Bizzarri-Schmid, S P Desai
Nov 1, 1985·Canadian Anaesthetists' Society Journal·J P GiffinC Capuano
May 1, 1987·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M AbdulatifI Saeed
Jan 1, 1990·Journal of Anesthesia·K FukushimaH Nagashima
May 12, 1994·European Journal of Pharmacology·A F DanilovD J Fedorov
Aug 10, 2000·Anesthesiology Clinics of North America·S L Shafer
Nov 5, 1997·The New England Journal of Medicine·R A Wiklund, S H Rosenbaum
Nov 1, 1990·Anaesthesia·A BenzerL Müller
Jan 1, 1992·Veterinary Surgery : VS·R E CluttonC J McGrath
Jul 23, 1983·British Medical Journal·M L Carter
Oct 29, 1983·British Medical Journal·A C Skinner
Jun 1, 1988·Archives of Emergency Medicine·R McGloneP Harris
Aug 1, 1984·Journal of Pharmacological Methods·R Hughes
Mar 1, 1982·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·E A Neill, D J Chapple
Mar 17, 2012·Veterinary Anaesthesia and Analgesia·Gudrun SchöffmannEddie R Clutton
Jun 2, 2011·Veterinary Anaesthesia and Analgesia·Manuel Martin-FloresRobin D Gleed
Dec 1, 1983·Anaesthesia·K Alegesan
Dec 1, 1983·Anaesthesia·L D Booij
Jan 1, 1989·Acta Anaesthesiologica Scandinavica·L BerntmanH Yousef
Apr 1, 1987·Acta Anaesthesiologica Scandinavica·A NilssonM P Persson
Jul 1, 1987·Acta Anaesthesiologica Scandinavica·R OrkoP H Rosenberg
Sep 1, 1986·Anaesthesia·J P Payne
Jul 13, 2005·Veterinary Anaesthesia and Analgesia·Marcelo R KastrupIgnacio A Gomez de Segura
Oct 20, 2017·Korean journal of anesthesiology·Yong Beom KimHong Seuk Yang
Jun 1, 1991·Transplantation Proceedings·R H Wiesner
Nov 1, 1985·Canadian Anaesthetists' Society Journal·H K GyasiY Adu-Gyamfi
Feb 1, 1988·Acta Anaesthesiologica Scandinavica·B N AndersenB Juhl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

© 2021 Meta ULC. All rights reserved